Lenvatinib 4mg Capsules contain lenvatinib, a targeted anticancer medicine that works by inhibiting several kinase pathways involved in tumour growth and the formation of blood vessels that supply tumours. It is used in specific cancer treatment settings, including certain differentiated thyroid cancers, advanced renal cell carcinoma, unresectable hepatocellular carcinoma and selected advanced or recurrent endometrial cancers, depending on the treatment regimen. Lenvatinib may be prescribed alone or in combination with other medicines such as pembrolizumab or everolimus according to the type and stage of cancer. Treatment should be initiated and monitored by an experienced oncology healthcare professional.
Each capsule contains lenvatinib equivalent to 4mg of lenvatinib (as lenvatinib mesylate). The inactive ingredients include calcium carbonate, hydroxypropyl cellulose, low-substituted hydroxypropyl cellulose, mannitol, microcrystalline cellulose and talc. The capsule shell contains hypromellose, titanium dioxide and iron oxides, with pharmaceutical printing ingredients.
Take Lenvatinib 4mg exactly as prescribed by your oncologist. The capsule is taken orally and should be swallowed whole with water; do not crush or chew the capsule. The exact daily dose and whether it is used alone or together with another anticancer medicine depend on the type of cancer, treatment regimen and the patient's individual condition. Take it at approximately the same time each day and do not change, interrupt or restart treatment without your oncologist's instructions.
Lenvatinib 4mg is an oral targeted anticancer medicine containing 4mg of lenvatinib. It is used in specific cancer treatment settings under specialist medical supervision.
The active ingredient is lenvatinib, supplied as lenvatinib mesylate. Each capsule provides 4mg of lenvatinib.
Depending on the approved indication and treatment regimen, lenvatinib is used for certain differentiated thyroid cancers, advanced renal cell carcinoma, unresectable hepatocellular carcinoma and selected advanced or recurrent endometrial cancers.
Lenvatinib inhibits several kinase receptors, including VEGF receptors and FGF receptors, that are involved in blood-vessel formation, tumour growth and cancer progression.
Lenvatinib is generally classified as a targeted kinase inhibitor, rather than a conventional cytotoxic chemotherapy medicine. It targets specific signalling pathways involved in tumour growth and angiogenesis.
Yes. Lenvatinib is used for certain patients with locally recurrent or metastatic, progressive, radioactive-iodine-refractory differentiated thyroid cancer.
Yes. It can be used in specific advanced renal cell carcinoma treatment regimens, including combination treatment with pembrolizumab or everolimus depending on the patient's treatment history.
Yes. Lenvatinib is used as a first-line treatment for certain patients with unresectable hepatocellular carcinoma.
Take it exactly according to your oncologist's instructions. Swallow the capsule whole with water and do not crush or chew it.
No. Lenvatinib dosing may need to be adjusted by the oncologist depending on the cancer treatment plan, response and tolerability. Never change the dose yourself.
Lenvatinib 4mg products are available in different pack configurations depending on the market. A 30-capsule presentation is used for some registered products.
Storage requirements depend on the specific product. Follow the storage instructions printed on the original pack and keep the medicine protected from unsuitable temperature, moisture and unauthorized access.
Lenvatinib products are subject to Pakistan's pharmaceutical registration and supply requirements. DRAP maintains a registered-drug database and states that medicines supplied in Pakistan generally need to be registered unless an applicable exemption or special permission applies. Current registration, supplier status and availability should therefore be verified before listing the product for sale.
Yes. Lenvatinib is a prescription-only medicine and should be used under specialist medical supervision.
Customers Reviews For Lenvatinib 4mg Capsules in Pakistan